Log in
Enquire now
‌

US Patent 11306066 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Monash University
Monash University
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11306066
Date of Patent
April 19, 2022
Patent Application Number
15572554
Date Filed
May 6, 2016
Patent Citations
‌
US Patent 10787668 Fibrotic treatment
‌
US Patent 10100311 Fibrotic treatment
Patent Primary Examiner
‌
Joseph R Kosack
CPC Code
‌
A61K 31/352
‌
A61K 31/35
‌
C07D 309/32
‌
C07D 311/74
‌
C07D 311/02
‌
C07D 311/00
‌
A61P 25/28
‌
A61K 31/351

The present disclosure relates generally, but not exclusively, to compounds and their use in therapy, to compositions and agents comprising said compounds, to methods of treatment using said compounds, and their use in the manufacture of medicaments. The disclosure further relates to inhibitors of IRAP and their use in the treatment or prevention of Alzheimer's disease and the treatment and prevention of memory and cognitive disorders.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11306066 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us